BioSyent Inc.
BIOYF
$10.61
-$0.09-0.81%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.45M | 6.18M | 5.92M | 5.62M | 5.31M |
| Total Depreciation and Amortization | 596.50K | 578.30K | 479.60K | 459.40K | 400.80K |
| Total Amortization of Deferred Charges | 13.50K | 38.10K | 75.70K | 31.20K | 28.00K |
| Total Other Non-Cash Items | 35.60K | 170.90K | 150.20K | 109.70K | -69.70K |
| Change in Net Operating Assets | -576.90K | -1.07M | 2.09M | -1.11M | 644.00K |
| Cash from Operations | 6.52M | 5.89M | 8.72M | 5.11M | 6.31M |
| Capital Expenditure | -28.00K | -24.50K | -42.90K | -35.40K | -23.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.95M | 1.86M | -2.14M | 2.96M | 2.40M |
| Cash from Investing | 2.92M | 1.83M | -2.19M | 2.92M | 2.38M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -196.70K | -191.50K | -188.10K | -185.70K | -183.20K |
| Issuance of Common Stock | 99.20K | 261.40K | 277.20K | 308.90K | 250.40K |
| Repurchase of Common Stock | -1.01M | -4.78M | -4.79M | -5.14M | -5.76M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.61M | -1.57M | -1.55M | -1.52M | -1.52M |
| Other Financing Activities | -49.30K | -51.80K | -54.30K | -56.70K | -59.20K |
| Cash from Financing | -2.42M | -4.96M | -4.93M | -5.13M | -5.68M |
| Foreign Exchange rate Adjustments | -9.30K | 21.90K | -2.10K | 3.10K | 3.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.01M | 2.78M | 1.60M | 2.90M | 3.02M |